Breakthroughs in tricuspid and mitral valve repair signal progress in heart treatment. BEIJING, June 3, 2025 /PRNewswire/ -- ...

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day follow-up results of TRINITY Trial of LuX-Valve Plus, a ...

I've been diagnosed with atrial fibrillation. I've read that it puts me at greater risk of stroke. Can you tell me more about ...

Community cardiology specialist Dr Peter Savill discusses five key challenges for GPs in the management of atrial ...

CoreMap today announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug ...

Seoul Metropolitan Government Boramae Hospital, operated by Seoul National University Hospital, successfully performed a left ...

The global heart closure devices market is poised for impressive growth, projected to expand from a valuation of USD 2.71 billion in 2023 to reach approximately USD 10.88 billion by 2033, registering ...

A recent subanalysis of the EAST-AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial) suggests a stronger benefit of early rhythm control (ERC) in patients with atrial ...

Vandalia Health Mon Medical Center recently achieved another first-in-state in heart care by combining two technologies to ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused in older populations due to concerns about bleeding. This study aimed to ...

There is significant risk for subsequent stroke in patients hospitalized for acute exacerbation of COPD with atrial fibrillation.